FDA officials have opened a safety review of two injectable RSV drugs used to protect babies and toddlers from the ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

Federal health officials are reviewing the safety of two injectable drugs used to protect babies and toddlers from the RSV virus.

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

What Is Respiratory Syncytial Virus (RSV)? Respiratory syncytial (sin-SISH-ul) virus (RSV) is a major cause of respiratory illness in children. The virus usually causes a common cold. But sometimes it ...

This is read by an automated voice. Please report any issues or inconsistencies here. The leading cause of infant hospitalization, RSV can trigger severe pneumonia and lung infections. Health ...

This story was originally published in 2022; it has since been updated. It started with a tickle in your throat. Then, it evolved into congestion, and maybe a little cough. Perhaps you lost your voice ...

This article is part of “Innovations In: RSV,” an editorially independent special report that was produced with financial support from MSD, Sanofi and AstraZeneca. Susan Green developed a stubborn ...

The UK's medicines regulator has approved GSK's Blujepa for treating UTIs in females aged 12 and older. Blujepa's active ingredient, gepotidacin, combats drug-resistant infections by blocking ...